EMA’s CHMP Recommends Yervoy for Patients 12 and Older with Advanced Melanoma
News
Yervoy (ipilimumab) has received a positive review by the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP), recommending its approval for the treatment of unresectable or ... Read more